RRE Ventures (RREVU) director-affiliated LLC awarded 250,000 warrants and Class B shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
RRE Ventures Acquisition Corp. director awards via affiliated LLC show compensation-style grants rather than open-market trades. Keegan Investment Holdings, LLC, an entity associated with director Brian Frederick Daly, received 250,000 private placement warrants at $1.00 each, exercisable for Class A Ordinary Shares at $11.50 per share after the company’s initial business combination. The same LLC also received 75,000 and then an additional 30,000 Class B Ordinary Shares, which are convertible into Class A Ordinary Shares on a one-for-one basis with no expiration.
Positive
- None.
Negative
- None.
Insights
Filing shows routine equity awards to an entity linked to a director.
The transactions reflect grant/award acquisitions of warrants and Class B Ordinary Shares by Keegan Investment Holdings, LLC, which is associated with director Brian Frederick Daly. These are compensation-style awards, not open-market purchases or sales, so they carry weaker signaling value about near-term stock views.
The LLC now holds 250,000 private placement warrants at an $11.50 exercise price and a total of 105,000 Class B Ordinary Shares. The Class B shares automatically convert into Class A shares at the time of the issuer’s initial business combination, or earlier at the reporting person’s option, which ties ultimate value to that future transaction.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Daly Brian Frederick
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Warrant | 250,000 | $1.00 | $250K |
| Grant/Award | Class B Ordinary Shares | 30,000 | $0.00 | -- |
| Grant/Award | Class B Ordinary Shares | 75,000 | $0.00 | -- |
Holdings After Transaction:
Warrant — 250,000 shares (Indirect, By Keegan Investment Holdings, LLC);
Class B Ordinary Shares — 105,000 shares (Indirect, By Keegan Investment Holdings, LLC)
Footnotes (1)
- The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date. These securities were previously reported on a Form 3 filed by the Reporting Person. The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation.
Key Figures
Private placement warrants granted: 250,000 warrants
Warrant exercise price: $11.50 per share
Class B shares granted (first grant): 75,000 shares
+2 more
5 metrics
Private placement warrants granted
250,000 warrants
Grant to Keegan Investment Holdings, LLC at $1.00 per warrant
Warrant exercise price
$11.50 per share
Exercise price for Class A Ordinary Shares under the warrants
Class B shares granted (first grant)
75,000 shares
Class B Ordinary Shares awarded on March 25, 2026
Class B shares granted (second grant)
30,000 shares
Additional Class B Ordinary Shares awarded on March 28, 2026
Total Class B shares after grants
105,000 shares
Total Class B Ordinary Shares held by Keegan Investment Holdings, LLC
Key Terms
private placement warrants, Class B Ordinary Shares, initial business combination, Form 3, +1 more
5 terms
private placement warrants financial
"The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination"
Private placement warrants are tradable coupons given directly to a limited group of investors that let the holder buy a company's shares at a fixed price before a set expiration date. They matter to investors because they can provide extra upside if the stock rises and give companies a way to raise money outside a public offering, but they also can increase the number of shares outstanding (dilution) and therefore affect share value and investor returns.
initial business combination financial
"at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person"
An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.
Form 3 regulatory
"These securities were previously reported on a Form 3 filed by the Reporting Person"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
liquidation financial
"will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation"
Liquidation is the process of turning a company’s assets into cash to pay off debts and close the business, often by selling property, inventory or investments. For investors it matters because liquidation determines whether there will be any money left for shareholders after creditors are paid and how much they might recover — like a garage sale where items are sold to settle bills, with leftovers (if any) shared last.
FAQ
What did RRE Ventures Acquisition Corp. director Brian Frederick Daly report in this Form 4 for RREVU?
The filing reports that an entity associated with director Brian Frederick Daly received equity awards. Keegan Investment Holdings, LLC acquired 250,000 private placement warrants and multiple grants of Class B Ordinary Shares that are convertible into Class A Ordinary Shares on a one-for-one basis.
How many private placement warrants were granted in the RREVU Form 4 filing?
Keegan Investment Holdings, LLC received 250,000 private placement warrants. Each warrant has an exercise price of $11.50 per Class A Ordinary Share and becomes exercisable 30 days after completion of RRE Ventures Acquisition Corp.’s initial business combination, then expires five years after that combination or earlier upon liquidation.
Are the transactions in this RRE Ventures Acquisition Corp. Form 4 open-market buys or sales?
No, the transactions are coded as grant or award acquisitions, not open-market buys or sales. The Form 4 describes compensation-style awards of private placement warrants and Class B Ordinary Shares to Keegan Investment Holdings, LLC, an entity through which the reporting person holds an indirect ownership interest.
When do the private placement warrants reported for RREVU become exercisable and when do they expire?
The private placement warrants become exercisable 30 days after completion of RRE Ventures Acquisition Corp.’s initial business combination. They expire five years after that business combination is completed, or earlier if the company is liquidated, according to the footnote disclosure in the filing.